Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
NASDAQ
2B
Biotechnology
Next Earning date - 27 Feb 2025
2B
Biotechnology
Next Earning date - 27 Feb 2025
Relative Strenght
59Volume Buzz
-49%Earning Acce
NoDist 52w H.
13%